If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.
| pathogenic | likely pathogenic | uncertain significance | likely benign | benign | not provided | total |
|---|---|---|---|---|---|---|
| 0 | 0 | 81 | 2 | 0 | 7 | 90 |
Condition and significance breakdown #
Total conditions: 11
| Condition | uncertain significance | likely benign | not provided | total |
|---|---|---|---|---|
| not specified | 81 | 1 | 0 | 82 |
| Malignant tumor of urinary bladder | 0 | 0 | 2 | 2 |
| Ovarian serous cystadenocarcinoma | 0 | 0 | 2 | 2 |
| Acute myeloid leukemia | 0 | 0 | 1 | 1 |
| Familial cancer of breast | 0 | 0 | 1 | 1 |
| Gastric cancer | 0 | 0 | 1 | 1 |
| Hepatocellular carcinoma | 0 | 0 | 1 | 1 |
| Sarcoma | 0 | 0 | 1 | 1 |
| Thymoma | 0 | 0 | 1 | 1 |
| Uterine carcinosarcoma | 0 | 0 | 1 | 1 |
| not provided | 0 | 1 | 0 | 1 |
Submitter and significance breakdown #
Total submitters: 3
| Submitter | uncertain significance | likely benign | not provided | total |
|---|---|---|---|---|
| Ambry Genetics | 81 | 1 | 0 | 82 |
| Dr. Peter K. Rogan Lab, Western University | 0 | 0 | 7 | 7 |
| CeGaT Center for Human Genetics Tuebingen | 0 | 1 | 0 | 1 |